The 100 Diverse Corporate Leaders in STEM blog series features a new business executive Monday-Friday and the exemplary work his or her company is doing to support 21st century STEM learning and workforce development- particularly for women, minorities and under-represented groups. Learn more and download the whole copy at STEMConnector.org/100Diverse. Follow the conversation on social media using #100STEMLeaders. Today's Diverse Corporate Leader is Clint Lewis, executive vice president and president, U.S. operations at Zoetis.
Executive Vice President and President, U.S. Operations
Clint Lewis is executive vice president and president, U.S. operations at Zoetis. Clint has worked in the pharmaceutical industry for over 25 years, holding key positions of increasing responsibility in the areas of sales management, marketing and general management. In his current role, he oversees the management of the livestock and companion animal businesses in the United States, the largest region within Zoetis. Clint is also responsible for leading the global genetics business for Zoetis.
Clint is a member of the Executive Committee for the Animal Health Institute (AHI), the trade association for animal health companies in the U.S., and he recently served as AHI's immediate past chairman of the board. Clint currently serves on the Dean's Advisory Board for both Cornell's College of Veterinary Medicine and Western University's College of Veterinary Medicine. Clint is a national board member and ardent supporter of INROADS, Inc. and formerly served as a member of the Board of Trustees for his alma mater, Fairfield University.
Clint holds a bachelor’s degree in biology from Fairfield University and a Master of Business Administration degree in marketing from Fairleigh Dickinson University.
Zoetis is the leading animal health company, dedicated to supporting veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. Zoetis applies research to a broad and diverse range of species, therapeutic areas and geographic regions, and its research encompasses vaccines and medicines. In addition, its R&D activities include the development of genetic and diagnostic products as well as biodevices and engineering investments for in ovopoultry applications. In 2013, the company generated annual revenues of $4.6 billion. With approximately 9,800 employees worldwide at the beginning of 2014, including 1,100+ R&D specialists, Zoetis has a local presence in approximately 70 countries, including 27 manufacturing facilities in 10 countries.
Clint on Diversity and STEM
How has your corporation coordinated investment in education with future workforce needs?
Zoetis has been at the forefront of advancing diversity in STEM initiatives, specifically in educating the next generation of veterinarians. For six consecutive years, Zoetis has invited second- and third-year students of veterinary medicine to apply for the Zoetis Veterinary Student Scholarship Program. Since the launch of the scholarship program in the fall of 2010, more than $2.7 million in scholarship funding has been awarded to more than 1,100 exceptional veterinary students. In addition to traditional selection criteria of academic excellence and financial need, the scholarship focuses on meeting ongoing needs of the veterinary profession such as diversity, sustainability, leadership and fostering diverse careers paths in veterinary medicine. The scholarship complements a number of other Zoetis programs supporting the veterinary profession, including millions invested in universities, industry education and training, scholarships, and allied organizations each year.
How do you translate your work into innovation?
Zoetis is focused on continuously innovating to develop animal health solutions that meet the needs of those who raise and care for animals. R&D is at the core of our efforts to provide innovation outcomes that anticipate the future needs of veterinarians and livestock producers in their local markets around the globe. Our new product R&D leverages relevant discoveries from the agribusiness, pharmaceutical and biotechnology industries. Combining this capability with the most promising discoveries from existing Zoetis R&D generally yields a faster, less expensive and more predictable process and more sustainable pipeline as compared to human health R&D. Our R&D for existing products focuses on broadening and enhancing our existing portfolio through the addition of new species or claims, securing approvals in additional countries, or creating new combinations and reformulations that extend Zoetis innovations to a growing range of those who raise and care for animals worldwide.
Are you a mentor, and what is your view of mentorship?
Yes, I am a mentor, and I believe that mentorship is something that I must model every day -- not only because it’s the right thing to do in developing future diverse STEM talent -- but because it pays dividends for our business. One of the ways that I help instill the value of mentorship throughout Zoetis is by our active engagement in the INROADS organization. I am a national board member of INROADS, the nation’s largest non-profit source of paid internships for undergraduate, diverse youth. On behalf of Zoetis, I commit to providing a multi-year professional opportunity for four interns, and consider the interns for full-time employment upon graduation. We work with them to create, implement and monitor a career development plan, designate a business advisor to evaluate their progress, and offer guidance throughout the process. As a corporate sponsor, Zoetis pays an annual sponsorship fee to INROADS, as well as a competitive salary for the interns.